Associations - CD5 positive

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

CD5 positive	Marginal Zone Lymphoma	CD5 positive	Marginal Zone Lymphoma	rituximab Resistant: C3 – Early Trials rituximab Resistant : C3	rituximab Resistant: C3 – Early Trials rituximab Resistant : C3
CD5 positive	Diffuse Large B Cell Lymphoma	CD5 positive	Diffuse Large B Cell Lymphoma	methotrexate IV Sensitive: C3 – Early Trials methotrexate IV Sensitive : C3	methotrexate IV Sensitive: C3 – Early Trials methotrexate IV Sensitive : C3